Intellia Therapeutics, Inc. (NTLA)
12.58
-0.49
(-3.75%)
USD |
NASDAQ |
Oct 12, 16:00
12.46
-0.12
(-0.91%)
Pre-Market: 08:46
Intellia Therapeutics Free Cash Flow : -348.69M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -348.69M |
| March 31, 2026 | -363.62M |
| December 31, 2025 | -395.86M |
| September 30, 2025 | -412.63M |
| June 30, 2025 | -421.82M |
| March 31, 2025 | -381.16M |
| December 31, 2024 | -354.66M |
| September 30, 2024 | -363.06M |
| June 30, 2024 | -382.65M |
| March 31, 2024 | -418.08M |
| December 31, 2023 | -408.07M |
| September 30, 2023 | -407.28M |
| June 30, 2023 | -384.33M |
| March 31, 2023 | -378.78M |
| December 31, 2022 | -346.84M |
| September 30, 2022 | -310.58M |
| June 30, 2022 | -297.38M |
| March 31, 2022 | -264.23M |
| December 31, 2021 | -237.79M |
| September 30, 2021 | -221.50M |
| Date | Value |
|---|---|
| June 30, 2021 | -181.20M |
| March 31, 2021 | -68.90M |
| December 31, 2020 | -53.50M |
| September 30, 2020 | -43.50M |
| June 30, 2020 | -41.44M |
| March 31, 2020 | -126.44M |
| December 31, 2019 | -110.03M |
| September 30, 2019 | -88.93M |
| June 30, 2019 | -76.20M |
| March 31, 2019 | -70.98M |
| December 31, 2018 | -67.62M |
| September 30, 2018 | -81.19M |
| June 30, 2018 | -85.87M |
| March 31, 2018 | -79.43M |
| December 31, 2017 | -75.37M |
| September 30, 2017 | -69.48M |
| June 30, 2017 | -58.54M |
| March 31, 2017 | 24.81M |
| December 31, 2016 | 29.94M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -93.22M |
| Beam Therapeutics, Inc. | -372.77M |
| Prime Medicine, Inc. | -156.85M |
| Moderna, Inc. | -1.244B |
| Q32 Bio, Inc. | -19.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -83.11M |
| Cash from Investing (Quarterly) | -141.57M |
| Cash from Financing (Quarterly) | 196.12M |
| Free Cash Flow Per Share (Quarterly) | -0.6362 |
| Free Cash Flow to Equity (Quarterly) | -77.84M |
| Free Cash Flow to Firm (Quarterly) | -84.92M |
| Free Cash Flow Yield | -23.19% |